| |
|
|
Session 33
Oral Abstract Presentations Clinical Trials in Resource-Limited Settings Thursday 4 - 6:15 pm Ballroom C |
| Moderators: | Philip Goulder Univ of Oxford, UK and Etienne Karita Elizabeth Glaser Pediatric AIDS Fndn, Kampaloa, Uganda |
| 4:00 168 | Complete Blood Count as a Surrogate CD4 Marker for HIV Monitoring in Resource-limited Settings R. Y. Chen*1,2, A. O. Westfall1, M. Hardin3, S. H. Vermund1, M. S. Saag1 1Univ of Alabama at Birmingham; 2Birmingham VA Med Ctr, AL; and 3Univ of Alabama, Tuscaloosa |
| 4:15 169 | Knowledge, Attitudes, Beliefs, and Practices Regarding Antiretroviral Therapy in HIV-infected Adults in Soweto, South Africa J Nachega*1, D A Lehman1, D Hlatshwayo2, R Mothopeng2, A Karstaedt2, R E Chaisson1 1Johns Hopkins Univ, Baltimore, MD and 2Wits Univ, Johannesburg, South Africa |
| 4:30 170 | Ability to Purchase and Secure Stable Therapy are Significant Predictors of Non-adherence to Antiretroviral Therapy in Kampala, Uganda J Byakika-Tusiime*1,2, JH Oyugi1,2,3, WA Tumwikirize1, ET Katabira1,2, PN Mugyenyi 2,4, DR Bangsberg2,3 1Makerere Univ, Kampala, Uganda; 2Academic Alliance for AIDS Care and Prevention in Africa, Kampala, Uganda; 3Univ of California at San Francisco; and 4Joint Clin Res Ctr, Kampala, Uganda |
| 4:45 171 | Preliminary Outcomes of Directly-observed Treatment of Advanced HIV Disease with ARVs (DOT-HAART) in Rural Haiti P. Farmer*1, F. Leandre2, S. Koenig1, P. Nevil2, J. Mukherjee1, J. Ferrer2, B. Walker1, C. Orelus2, M. Smith-Fawzi1 1Harvard Med Sch, Boston, MA and 2Zanmi Lasante, Cange, Haiti |
| 5:00 172 | The Malawian Antiretroviral Program: The First Year Experience with Triomune M Hosseinipour*1, D Namarika2, K Magomero2, F Martinson1, S Phiri3, F Neuhann3, S Luftl2 1Univ of North Carolina Project, Lilongwe Malawi; 2Lilongwe Central Hosp, Lilongwe, Malawi; and 3Lighthouse Clin, Lilongwe, Malawi |
| 5:15 173 | Long-term Follow-up of a Cohort Patients under HAART in Senegal Christian Laurent1, Ndeye Fatou 2, Ngom Gueye2, Ndella Diakhaté2, Adama Ndir3, Mandoumbé Gueye4, Isabelle Laniece1, Mame Awa Faye2, Coumba Touré Kane5, Florian Liégeois1, Roland Landman6, Souleymane Mboup5, Ibrahima Ndoye3, Eric Delaporte1, Papa Salif Sow*2 1Inst de Recherche pour le Dev IRD, UR 36 and Univ of Montpellier, France; 2Fann Univ Hosp, Dakar, Senegal; 3Natl AIDS Prgm, Dakar, Senegal; 4Military Hosp, Dakar, Senegal; 5Le Dantec Univ Hosp, Dakar, Senegal; and 6French Inst of Tropical Med and Epid, Paris, France |
| 5:30 174 | Safety, Tolerability, and Effectiveness of Generic HAART Regimens in South India N Kumarasamy*1, S Chaguturu2, A Mahajan2, T Yepthomi1, P Balakrishnan1, A Kalamalini1, T Flanigan3, S Solomon1, K Mayer3 1Y R Gaitonde Ctr for AIDS Res and Educ, Chennai, Tamil Nadu, India; 2Brown Med Sch, Providence, RI; and 3Miriam Hosp, Providence, RI |
| 5:45 175 | Increase in Survival in HIV-1 Infected Subjects in Matola, Mozambique, after the Introduction of Combination Therapy With Generic-manufactured Antiretrovirals: Preliminary Results from the DREAM Cohort L Emberti Gialloreti*1, A De Luca2, CF Perno3, G Liotta3, P Narciso4, N Abdel Magid5, MC Marazzi6, S Vella7, L Palombi3 1Community of Sant'Egidio, Rome, Italy; 2Catholic Univ, Rome, Italy; 3Tor Vergata Univ, Rome, Italy; 4Inst Natl per le Malattie Infettive L Spallanzani, Rome, Italy; 5Direccao Provincial de Saùde, Maputo, Mozambique; 6LUMSA Univ, Rome, Italy; and 7Inst Superiore di Sanità, Rome, Italy |
| 6:00 175lb | Development of Affordable, Portable CD4 Counts for Resource-Poor Settings Using Microchips. W Rodriguez*1,2, M Mohanty3, N Christodoulides3, A Goodey3, D Romanovicz3, M Ali3, P Floriano3, B Walker1,2, J McDevitt3 1Partners AIDS Research Center; 2Harvard Medical School, Boston, MA; and 3Univ of Texas, Austin, TX |